Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma-sensitivity of TTF-1 is superior to napsin

被引:38
作者
Terra, Simone B. S. P. [1 ]
Aubry, Marie Christine [1 ]
Yi, Eunhee S. [1 ]
Boland, Jennifer M. [1 ]
机构
[1] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA
关键词
Lung sarcomatoid carcinoma; TTF-1; Napsin; PROTEASE-LIKE PROTEIN; DIFFERENTIAL-DIAGNOSIS; CELL CARCINOMAS; LUNG; MESOTHELIOMA; EXPRESSION; KIDNEY; TISSUE; MARKER; ADENOCARCINOMA;
D O I
10.1016/j.humpath.2013.09.005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Immunohistochemistry is often used to distinguish pulmonary sarcomatoid carcinoma from morphologic mimics. Napsin-A is a pulmonary adenocarcinoma marker, but literature on expression in sarcomatoid carcinoma is limited. Thirty-six cases of sarcomatoid carcinoma were stained for napsin, TTF-1, Oscar, CAM5.2, AE1/AE3, desmin, SMA, S-100, CK5/6, calretinin, D2-40, and WT1. Patients were 24 men and 12 women (mean, 70 years; range, 46-93). There were 27 pleomorphic carcinomas, 5 spindle cell carcinomas, 3 carcinosarcomas, and 1 giant cell carcinoma. Cases were positive for at least 1 keratin: AE1/3 was positive in all 36 cases; Oscar, in 34 cases (94%); and CAM5.2, in 32 cases (89%, weaker/more focal). Napsin was positive in 14 cases (39%): 8 diffuse, 3 focal, and 3 rare cells. TTF-1 was positive in 22 cases (61%): 15 diffuse, 3 focal, and 4 rare cells. No cases were napsin positive and negative for TTF-1. Variable staining for mesothelial markers was observed, including positivity for calretinin (12 cases, 33%), WT1 (6 cases, 17%), D2-40 (5 cases, 14%), and CK5/6 (9 cases, 25%). Mesenchymal markers were also sometimes positive (usually focal), including S-100 (4 cases, 11%), desmin (4 cases, 11%), and SMA (7 cases, 19%, 1 diffuse). In conclusion, TTF-1 is more sensitive than napsin for detection of sarcomatoid carcinoma, and no cases were positive for napsin but negative for TTF-1. CAM5.2 is less sensitive than AE1/AE3 and Oscar. Use of a thoughtful immunohistochemical panel is important in the evaluation of sarcomatoid carcinoma because mesothelial and mesenchymal markers can be expressed. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:294 / 302
页数:9
相关论文
共 37 条
[1]  
[Anonymous], 2004, PATHOLOGY GENETICS T
[2]   Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms [J].
Attanoos, RL ;
Dojcinov, SD ;
Webb, R ;
Gibbs, AR .
HISTOPATHOLOGY, 2000, 37 (03) :224-231
[3]   Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma [J].
Bishop, Justin A. ;
Sharma, Rajni ;
Illei, Peter B. .
HUMAN PATHOLOGY, 2010, 41 (01) :20-25
[4]   Involvement of napsin A in the C- and N-terminal processing of surfactant protein B in type-II pneumocytes of the human lung [J].
Brasch, F ;
Ochs, M ;
Kähne, T ;
Guttentag, S ;
Schauer-Vukasinovic, V ;
Derrick, M ;
Johnen, G ;
Kapp, N ;
Müller, KM ;
Richter, J ;
Giller, T ;
Hawgood, S ;
Bühling, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (49) :49006-49014
[5]   Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma [J].
Cheng, YL ;
Lee, YC ;
Shih, JY ;
Wu, CT .
LUNG CANCER, 2001, 34 (01) :91-97
[6]   Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas [J].
Chuman, Y ;
Bergman, AC ;
Ueno, T ;
Saito, S ;
Sakaguchi, K ;
Alaiya, AA ;
Franzén, B ;
Bergman, T ;
Arnott, D ;
Auer, G ;
Appella, E ;
Jörnvall, H ;
Linder, S .
FEBS LETTERS, 1999, 462 (1-2) :129-134
[7]  
FISHBACK NF, 1994, CANCER-AM CANCER SOC, V73, P2936, DOI 10.1002/1097-0142(19940615)73:12<2936::AID-CNCR2820731210>3.0.CO
[8]  
2-U
[9]   Pulmonary carcinosarcoma: Immunohistochemical and ultrastructural studies [J].
Haraguchi, S ;
Fukuda, Y ;
Sugisaki, Y ;
Yamanaka, N .
PATHOLOGY INTERNATIONAL, 1999, 49 (10) :903-908
[10]   Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A [J].
Hirano, T ;
Auer, C ;
Maeda, M ;
Hagiwara, Y ;
Okada, S ;
Ohira, T ;
Okuzawa, K ;
Fujioka, K ;
Franzén, B ;
Hibi, N ;
Seito, T ;
Ebihara, Y ;
Kato, H .
JAPANESE JOURNAL OF CANCER RESEARCH, 2000, 91 (10) :1015-1021